200 related articles for article (PubMed ID: 31989362)
1. Investigations of Piperazine Derivatives as Intestinal Permeation Enhancers in Isolated Rat Intestinal Tissue Mucosae.
Stuettgen V; Brayden DJ
AAPS J; 2020 Jan; 22(2):33. PubMed ID: 31989362
[TBL] [Abstract][Full Text] [Related]
2. An Assessment of the Permeation Enhancer, 1-phenyl-piperazine (PPZ), on Paracellular Flux Across Rat Intestinal Mucosae in Ussing Chambers.
Bzik VA; Brayden DJ
Pharm Res; 2016 Oct; 33(10):2506-16. PubMed ID: 27387171
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers.
Petersen SB; Nolan G; Maher S; Rahbek UL; Guldbrandt M; Brayden DJ
Eur J Pharm Sci; 2012 Nov; 47(4):701-12. PubMed ID: 22952065
[TBL] [Abstract][Full Text] [Related]
4. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
Brayden DJ; Maher S; Bahar B; Walsh E
Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
[TBL] [Abstract][Full Text] [Related]
5. Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers.
Fattah S; Ismaiel M; Murphy B; Rulikowska A; Frias JM; Winter DC; Brayden DJ
Eur J Pharm Sci; 2020 Nov; 154():105509. PubMed ID: 32777258
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
Maher S; Kennelly R; Bzik VA; Baird AW; Wang X; Winter D; Brayden DJ
Eur J Pharm Sci; 2009 Nov; 38(4):291-300. PubMed ID: 19737613
[TBL] [Abstract][Full Text] [Related]
7. Melittin as a permeability enhancer II: in vitro investigations in human mucus secreting intestinal monolayers and rat colonic mucosae.
Maher S; Feighery L; Brayden DJ; McClean S
Pharm Res; 2007 Jul; 24(7):1346-56. PubMed ID: 17380268
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C
Twarog C; McCartney F; Harrison SM; Illel B; Fattal E; Brayden DJ
Eur J Pharm Sci; 2021 Mar; 158():105685. PubMed ID: 33359131
[TBL] [Abstract][Full Text] [Related]
9. Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.
Maher S; Medani M; Carballeira NN; Winter DC; Baird AW; Brayden DJ
AAPS J; 2017 Jan; 19(1):244-253. PubMed ID: 27739012
[TBL] [Abstract][Full Text] [Related]
10. Permeability-enhancing effects of three laurate-disaccharide monoesters across isolated rat intestinal mucosae.
McCartney F; Perinelli DR; Tiboni M; Cavanagh R; Lucarini S; Filippo Palmieri G; Casettari L; Brayden DJ
Int J Pharm; 2021 May; 601():120593. PubMed ID: 33857587
[TBL] [Abstract][Full Text] [Related]
11. Structure-Function Analysis of Phenylpiperazine Derivatives as Intestinal Permeation Enhancers.
Fein KC; Lamson NG; Whitehead KA
Pharm Res; 2017 Jun; 34(6):1320-1329. PubMed ID: 28374339
[TBL] [Abstract][Full Text] [Related]
12. Sodium glycodeoxycholate and sodium deoxycholate as epithelial permeation enhancers: in vitro and ex vivo intestinal and buccal bioassays.
Brayden DJ; Stuettgen V
Eur J Pharm Sci; 2021 Apr; 159():105737. PubMed ID: 33524502
[TBL] [Abstract][Full Text] [Related]
13. Intestinal permeation enhancers enable oral delivery of macromolecules up to 70 kDa in size.
Fein KC; Gleeson JP; Newby AN; Whitehead KA
Eur J Pharm Biopharm; 2022 Jan; 170():70-76. PubMed ID: 34879228
[TBL] [Abstract][Full Text] [Related]
14. The pH of Piperazine Derivative Solutions Predicts Their Utility as Transepithelial Permeation Enhancers.
Lamson NG; Cusimano G; Suri K; Zhang A; Whitehead KA
Mol Pharm; 2016 Feb; 13(2):578-85. PubMed ID: 26730955
[TBL] [Abstract][Full Text] [Related]
15. Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro.
Feighery LM; Cochrane SW; Quinn T; Baird AW; O'Toole D; Owens SE; O'Donoghue D; Mrsny RJ; Brayden DJ
Pharm Res; 2008 Jun; 25(6):1377-86. PubMed ID: 18163202
[TBL] [Abstract][Full Text] [Related]
16. Investigation of coco-glucoside as a novel intestinal permeation enhancer in rat models.
Aguirre TA; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
Eur J Pharm Biopharm; 2014 Nov; 88(3):856-65. PubMed ID: 25445305
[TBL] [Abstract][Full Text] [Related]
17. The mycotoxin patulin increases colonic epithelial permeability in vitro.
Mohan HM; Collins D; Maher S; Walsh EG; Winter DC; O'Brien PJ; Brayden DJ; Baird AW
Food Chem Toxicol; 2012 Nov; 50(11):4097-102. PubMed ID: 22906760
[TBL] [Abstract][Full Text] [Related]
18. Labrasol® is an efficacious intestinal permeation enhancer across rat intestine: Ex vivo and in vivo rat studies.
McCartney F; Jannin V; Chevrier S; Boulghobra H; Hristov DR; Ritter N; Miolane C; Chavant Y; Demarne F; Brayden DJ
J Control Release; 2019 Sep; 310():115-126. PubMed ID: 31401199
[TBL] [Abstract][Full Text] [Related]
19. Effects of surfactant-based permeation enhancers on mannitol permeability, histology, and electrogenic ion transport responses in excised rat colonic mucosae.
Maher S; Heade J; McCartney F; Waters S; Bleiel SB; Brayden DJ
Int J Pharm; 2018 Mar; 539(1-2):11-22. PubMed ID: 29341916
[TBL] [Abstract][Full Text] [Related]
20. CriticalSorb™ promotes permeation of flux markers across isolated rat intestinal mucosae and Caco-2 monolayers.
Brayden DJ; Bzik VA; Lewis AL; Illum L
Pharm Res; 2012 Sep; 29(9):2543-54. PubMed ID: 22638869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
